Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Treatment of infantile hemangioma with optimal pulse technology

This new generation IPL with OPT can be considered a safe and effective modality for the treatment of infantile hemangioma. Marked improvement was noted in the majority of study patients and adverse events were noted to be minimal.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a clinical trial of 62 infants with infantile hemangiomas treated with intense pulsed light using optimal pulse technology, typically four to five sessions. They report improvement in 76% of lesions, with transient adverse events in under 5% of treatments and no scarring or pigmentary changes. The authors conclude the approach is safe and effective.

Participants
62
Who or what was studied
Infants with infantile hemangioma, mean age 6 months, Fitzpatrick skin types III or IV
Limits stated in the abstract
The abstract describes a single clinical trial without a control group and reports improvement based on comparison of photographs and parental satisfaction scores.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Adverse event. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies